4//SEC Filing
Avista Capital Partners III GP, L.P. 4
Accession 0001104659-20-004321
CIK 0001739426other
Filed
Jan 14, 7:00 PM ET
Accepted
Jan 15, 4:11 PM ET
Size
16.0 KB
Accession
0001104659-20-004321
Insider Transaction Report
Form 4
Avista Healthcare Partners GP, Ltd.
10% Owner
Transactions
- Purchase
Ordinary Shares
2020-01-13$5.00/sh+1,250,000$6,250,000→ 15,730,864 total(indirect: By Avista Capital investment fund)
Holdings
- 1,032,995(indirect: By Avista Capital investment fund)
Ordinary Shares
- 4,936,926(indirect: By Avista Capital investment fund)
Ordinary Shares
Orbit Co-Invest I LLC
10% Owner
Transactions
- Purchase
Ordinary Shares
2020-01-13$5.00/sh+1,250,000$6,250,000→ 15,730,864 total(indirect: By Avista Capital investment fund)
Holdings
- 1,032,995(indirect: By Avista Capital investment fund)
Ordinary Shares
- 4,936,926(indirect: By Avista Capital investment fund)
Ordinary Shares
Avista Capital Partners III GP, L.P.
10% Owner
Transactions
- Purchase
Ordinary Shares
2020-01-13$5.00/sh+1,250,000$6,250,000→ 15,730,864 total(indirect: By Avista Capital investment fund)
Holdings
- 1,032,995(indirect: By Avista Capital investment fund)
Ordinary Shares
- 4,936,926(indirect: By Avista Capital investment fund)
Ordinary Shares
Avista Healthcare Partners, L.P.
10% Owner
Transactions
- Purchase
Ordinary Shares
2020-01-13$5.00/sh+1,250,000$6,250,000→ 15,730,864 total(indirect: By Avista Capital investment fund)
Holdings
- 4,936,926(indirect: By Avista Capital investment fund)
Ordinary Shares
- 1,032,995(indirect: By Avista Capital investment fund)
Ordinary Shares
Orbit Co-Invest III LLC
10% Owner
Transactions
- Purchase
Ordinary Shares
2020-01-13$5.00/sh+1,250,000$6,250,000→ 15,730,864 total(indirect: By Avista Capital investment fund)
Holdings
- 4,936,926(indirect: By Avista Capital investment fund)
Ordinary Shares
- 1,032,995(indirect: By Avista Capital investment fund)
Ordinary Shares
Footnotes (4)
- [F1]Represents 1,250,000 Ordinary Shares acquired by Avista Healthcare Partners, L.P. ("AHP") in the Issuer's underwritten public offering (the "Offering") that was completed on January 13, 2020. The acquisition price of $5.00 per Ordinary Share represents the public offering price in the Offering paid by AHP and does not give effect to the fee paid by the Issuer to Avista Capital Holdings, L.P., an affiliate of AHP, pursuant to the Fee Letter Agreement, dated January 8, 2020, among the Issuer, Avista Capital Holdings, L.P. and the other parties thereto, which was entered into in connection with the Offering.
- [F2]Represents shares of the Issuer held by AHP. Avista Healthcare Partners GP, Ltd. ("AHP GP") is the general partner of AHP. As a result, AHP GP may be deemed to share voting and investment power with respect to the shares held by AHP. Each of AHP and AHP GP disclaims beneficial ownership of such shares, except to the extent of its pecuniary interest therein, and the inclusion of the shares in this report shall not be deemed to be an admission of beneficial ownership of the reported shares for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise.
- [F3]Represents shares of the Issuer held by Orbit Co-Invest I LLC. Avista Capital Partners III GP, L.P. ("ACP GP") is the manager of Orbit Co-Invest I LLC. As a result, ACP GP may be deemed to share voting and investment power with respect to the shares held by Orbit Co-Invest I LLC. Each of Orbit Co-Invest I LLC and ACP GP disclaims beneficial ownership of such shares, except to the extent of its pecuniary interest therein, and the inclusion of the shares in this report shall not be deemed to be an admission of beneficial ownership of the reported shares for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise.
- [F4]Represents shares of the Issuer held by Orbit Co-Invest III LLC. ACP GP is the manager of Orbit Co-Invest III LLC. As a result, ACP GP may be deemed to share voting and investment power with respect to the shares held by Orbit Co-Invest III LLC. Each of Orbit Co-Invest III LLC and ACP GP disclaims beneficial ownership of such shares, except to the extent of its pecuniary interest therein, and the inclusion of the shares in this report shall not be deemed to be an admission of beneficial ownership of the reported shares for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise.
Documents
Issuer
Osmotica Pharmaceuticals plc
CIK 0001739426
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001705722
Filing Metadata
- Form type
- 4
- Filed
- Jan 14, 7:00 PM ET
- Accepted
- Jan 15, 4:11 PM ET
- Size
- 16.0 KB